Finally, six m6A-related genes, namely, YTHDF1, YTHDF2, IGF2BP3, KIAA1429, METTL3, and ZC3H13, were recognized to constructed a m6A-based risk signature for HCC patients. The gene discussed is METTL3; the disease is hepatocellular carcinoma.